MSU's Skin Cancer Researchers

Richard Neubig

Richard Neubig, PhD, professor and chair of the Department of Pharmacology and Toxicology, has received numerous MSU Gran Fondo grants to search for new and better treatments for skin cancer. He is focusing his research on two promising avenues: one to prevent the often fatal form of skin cancer from metastasizing, and a second to keep it from returning after it goes into remission.

Read more: Promising new drug stops spread of melanoma by 90 percent

Jamie Bernard

Jamie Bernard, PhD, assistant professor in the Department of Pharmacology and Toxicology, is studying ways to prevent non-melanoma skin cancers by identifying compounds that prevent epidermal cell transformation. She has also studied the link between obesity and skin cancer and is beginning a new project to screen compounds that could prevent skin cells damaged by sun exposure from transforming to cancer, specifically basal cell and squamous cell, which account for more than three million diagnoses each year.

Michigan State University Department of Pharmacology and Toxicology

Through a grant funded by MSU Gran Fondo donations, skin cancer researcher Sean Misek, PhD, has found that new drug combinations may prevent resistance to melanoma treatments.